Created in 2014 (United States), TAVSCENZA own 19 sister brands and 2214 competing brands. TAVSCENZA is owned by Biomarin Pharmaceutical, listed on the stock exchange of New York The sector of TAVSCENZA is Biotechnology.

TAVSCENZA is a brand of Biomarin Pharmaceutical (BMRN) Share price

Share price and profitability of the share Biomarin Pharmaceutical (TAVSCENZA)

Buy Biomarin Pharmaceutical share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 80.91

Portfolio valuation
Biomarin Pharmaceutical (TAVSCENZA) over 5 years* USD 77.29

Stock market history Biomarin Pharmaceutical (TAVSCENZA)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more